뒤로
Biolight Life Sciences Ltd(BLLSF) 가격
BLLSF 주가 차트
BLLSF 재무
Biolight Life Sciences Ltd
$0
0%
$0
종가: Feb 06, 16:00:00 GMT-5
$0
0%
$0
애프터마켓: Feb 06, 20:00:00 GMT-5
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
BLLSF 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
Biolight Life Sciences Ltd의 주요 재무제표는 무엇인가요?
BLLSF의 주요 재무 비율은 무엇인가요?
Biolight Life Sciences Ltd의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Biolight Life Sciences Ltd은 수익성이 있나요?
Biolight Life Sciences Ltd에 부채가 있나요?
Biolight Life Sciences Ltd의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
BLLSF란 무엇인가요?
BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The firm provides each of the subsidiaries with ongoing support, resources and expertise in science, regulation, business development, and intellectual property. IOptima Novel Glaucoma Treatment is engaged in the development, manufacturing and distribution of novel surgical treatments for glaucoma. Micromedic Technologies Ltd focuses, through its investee companies, on the development and commercialization of novel molecular biomarkers related to cancer, including early detection of disease, genetic risk and optimization of treatment modalities.